Generic Cialis Daily ( Tadalafil )

Buy Generic Cialis Daily (Tadalafil) without prescription in Canada

In our Canadian pharmacy, you can buy Cialis Daily (Tadalafil) without a prescription, with delivery across Canada within 5‑14 days. Discreet and anonymous packaging.

Cialis Daily (tadalafil) is a once‑daily oral phosphodiesterase type 5 (PDE5) inhibitor used for the treatment of erectile dysfunction (ED), the signs and symptoms of benign prostatic hyperplasia (BPH), or both conditions together. It works by relaxing the smooth muscles of the penile arteries and the prostate and bladder neck, increasing blood flow to the penis during sexual stimulation and improving urinary flow in men with BPH. Because it is taken every day at a lower dose, it provides continuous 24‑hour coverage, allowing for spontaneous sexual activity without the need to plan around a pill.

Usual adult dose: The recommended dose for once‑daily use is 5 mg taken orally at approximately the same time each day, with or without food. For patients who are starting treatment or who experience bothersome side effects, the dose may be reduced to 2.5 mg once daily. The medication can be taken at any time of day, but a regular schedule helps maintain consistent blood levels. Sexual stimulation is required for an erection to occur. For men with both ED and BPH, the same 5 mg daily dose is used.

Dosage form: Oral film‑coated tablets: 2.5 mg and 5 mg of tadalafil. The 2.5 mg tablet is round and yellow; the 5 mg tablet is almond‑shaped and yellow.

Onset of action: When taken daily, tadalafil begins to provide coverage from the first day of treatment. Steady‑state plasma concentrations are reached within 5 days, and the medication is effective at any time during the 24‑hour dosing interval. There is no need to time sexual activity; erections can occur with stimulation throughout the day. For BPH, improvements in urinary symptoms are typically seen after 2 to 4 weeks of continuous therapy.

Duration of action: Because tadalafil is taken once daily, the therapeutic effect is continuous. The elimination half‑life of tadalafil is approximately 17.5 hours, which supports the 24‑hour coverage provided by daily dosing. If a dose is missed, therapeutic levels will decline, but coverage resumes with the next scheduled dose.

Alcohol recommendation: Alcohol consumption should be limited or avoided while taking Cialis Daily. Drinking alcohol can temporarily reduce the ability to get an erection, may lower blood pressure further, and can increase the risk of side effects such as headache, dizziness, flushing, and orthostatic hypotension. Heavy alcohol intake is particularly discouraged.

Most common side effects: Headache (3‑5%), dyspepsia (indigestion, 3‑4%), back pain (2‑3%), myalgia (muscle pain, 2‑3%), nasal congestion (1‑2%), flushing (1‑2%), and pain in the limbs. These effects are generally mild to moderate, transient, and tend to diminish with continued daily use. Rare but serious side effects include priapism (a prolonged, painful erection lasting more than 4 hours), sudden vision loss (non‑arteritic anterior ischaemic optic neuropathy, NAION), and sudden hearing loss.

Would you like to try Cialis Daily (Tadalafil) without a prescription?

General Information about Cialis Daily (Tadalafil)

• INN (International Nonproprietary Name): Tadalafil
• Brand names available in Canada: Cialis® (Eli Lilly Canada Inc.) is the original brand‑name product. Generic tadalafil tablets for daily use are widely available and include APO‑Tadalafil (Apotex Inc.), TEVA‑Tadalafil (Teva Canada Limited), Sandoz Tadalafil (Sandoz Canada Inc.), PMS‑Tadalafil (Pharmascience Inc.), JAMP‑Tadalafil (JAMP Pharma Corporation), M‑Tadalafil (Mantra Pharma Inc.), and others.
• ATC code: G04BE08 (urologicals, drugs used in erectile dysfunction).
• Dosage forms and strengths: Film‑coated tablets for daily use: 2.5 mg and 5 mg. Tablets of 10 mg and 20 mg are used for as‑needed dosing.
• Manufacturers in Canada: Eli Lilly Canada Inc. (Cialis), Apotex Inc., Teva Canada Limited, Sandoz Canada Inc., Pharmascience Inc., JAMP Pharma Corporation, Mantra Pharma Inc., and other generic manufacturers.
• Registration status in Canada: Approved by Health Canada. Cialis 2.5 mg (DIN 02391391) and 5 mg (DIN 02285737) are marketed for once‑daily use. Generic versions are also marketed.
• OTC / Rx classification: Prescription only (Rx). Tadalafil is a Schedule I drug under the Controlled Drugs and Substances Act. It requires a valid prescription from a licensed Canadian healthcare professional.

Mechanism of Action and Pharmacology

Tadalafil is a potent and selective, reversible inhibitor of cyclic guanosine monophosphate (cGMP)‑specific phosphodiesterase type 5 (PDE5). During sexual stimulation, nitric oxide is released from nerve endings and endothelial cells in the corpus cavernosum of the penis. Nitric oxide activates guanylate cyclase, increasing intracellular cGMP, which relaxes the smooth muscle of the penile arteries and corpus cavernosum, allowing blood to flow in and produce an erection. PDE5 normally degrades cGMP; by inhibiting PDE5, tadalafil allows cGMP to accumulate and persist, enhancing the erectile response. Tadalafil is approximately 700‑fold more selective for PDE5 than for PDE6 (found in the retina), which accounts for its low incidence of visual disturbances. In the prostate and bladder, PDE5 inhibition leads to smooth muscle relaxation, improving urinary flow and reducing the symptoms of BPH.

With once‑daily dosing of 2.5 mg or 5 mg, steady‑state plasma concentrations of tadalafil are achieved within 5 days. The long elimination half‑life of approximately 17.5 hours supports continuous 24‑hour coverage with a single daily tablet. Tadalafil is metabolized predominantly by cytochrome P450 3A4 (CYP3A4) to an inactive catechol metabolite and is excreted primarily in the faeces (approximately 61%) and urine (approximately 36%). Food does not affect absorption, so the tablet may be taken with or without meals. The daily dosing regimen provides a consistent therapeutic level, eliminating the need to time sexual activity and allowing for greater spontaneity compared with on‑demand dosing.

Indications

• Erectile Dysfunction (ED): Cialis Daily is indicated for the treatment of erectile dysfunction in adult men who anticipate frequent sexual activity (at least twice weekly). The once‑daily regimen provides continuous 24‑hour coverage, allowing for spontaneous sexual activity without the need to plan around a pill.
• Benign Prostatic Hyperplasia (BPH): Cialis Daily 5 mg is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia in adult men. It improves urinary flow, reduces hesitancy, and decreases the sensation of incomplete bladder emptying.
• ED and BPH Combined: For men who have both erectile dysfunction and the signs and symptoms of BPH, Cialis Daily 5 mg is indicated to treat both conditions simultaneously with a single daily tablet.
• Cialis Daily is not indicated for use in women or in children and adolescents under 18 years of age.

Important Warnings and Precautions

At‑risk groups

• Pregnancy and breastfeeding: Cialis Daily is not indicated for use by women. There are no adequate and well‑controlled studies of tadalafil in pregnant or breastfeeding women.
• Paediatrics (< 18 years): Tadalafil is not approved for use in children or adolescents for the treatment of ED or BPH.
• Elderly: No dose adjustment is required based on age alone. However, elderly patients may be more sensitive to the vasodilatory effects of tadalafil, and the risk of orthostatic hypotension may be increased. A starting dose of 2.5 mg daily may be considered.
• Cardiovascular disease: Sexual activity carries a degree of cardiac risk for patients with pre‑existing cardiovascular disease. Tadalafil has vasodilatory properties and can cause mild and transient decreases in blood pressure. It is contraindicated in patients with severe cardiovascular disease, including unstable angina, severe heart failure, and recent myocardial infarction or stroke (within the last 6 months).
• Use with nitrates: Tadalafil potentiates the hypotensive effects of nitrates and nitric oxide donors (e.g., nitroglycerin, isosorbide mononitrate, amyl nitrate). Concomitant use is absolutely contraindicated and can lead to a life‑threatening drop in blood pressure. This applies to all doses and formulations, including the 2.5 mg and 5 mg daily tablets.
• Use with guanylate cyclase stimulators: Concomitant use of tadalafil with riociguat (Adempas®) is contraindicated due to the risk of severe hypotension.
• Priapism: Prolonged erection (longer than 4 hours) has been reported rarely with PDE5 inhibitors. This is a medical emergency that can lead to permanent penile tissue damage and impotence. Men who experience an erection lasting more than 4 hours should seek immediate medical attention.
• Vision loss: Non‑arteritic anterior ischaemic optic neuropathy (NAION), a cause of sudden vision loss, has been reported rarely in temporal association with PDE5 inhibitor use. The risk may be increased in patients with a small cup‑to‑disc ratio, those with hypertension or diabetes, and smokers. Men who experience sudden vision loss should stop taking the drug and seek immediate medical care.
• Hearing loss: Sudden decrease or loss of hearing has been reported. Patients should discontinue tadalafil and seek prompt medical attention if this occurs.
• Renal impairment: Once‑daily tadalafil is not recommended in patients with severe renal impairment (creatinine clearance ≤ 30 mL/min). In patients with mild to moderate renal impairment (CrCl 31‑80 mL/min), no dose adjustment is required, though the 2.5 mg starting dose may be used.
• Hepatic impairment: In patients with mild or moderate hepatic impairment (Child‑Pugh A or B), the recommended dose is 2.5 mg once daily. Tadalafil has not been studied in patients with severe hepatic impairment (Child‑Pugh C) and is not recommended.
• Alpha‑blockers: Concomitant use of tadalafil with alpha‑adrenergic blocking agents (e.g., tamsulosin, doxazosin) may lead to additive vasodilation and symptomatic hypotension. The patient should be stable on alpha‑blocker therapy before initiating tadalafil daily, and tadalafil should be started at the lowest recommended dose (2.5 mg).
• Anatomical deformation of the penis: Use with caution in patients with anatomical deformation (e.g., Peyronie’s disease, angulation, cavernosal fibrosis) or conditions predisposing to priapism (e.g., sickle cell anaemia, multiple myeloma, leukaemia).
• Allergy: Do not take Cialis Daily if you have a known hypersensitivity to tadalafil or any of the tablet’s excipients.

Driving and alcohol

Tadalafil may cause dizziness, blurred vision, or fatigue. Patients should be aware of how they react to the medication before driving or operating heavy machinery. Alcohol consumption should be limited, as it may impair the ability to achieve an erection, lower blood pressure, and increase the risk of side effects such as headache, dizziness, and orthostatic hypotension. Heavy alcohol intake is particularly discouraged with Cialis Daily.

Dosage Instructions

• Erectile Dysfunction — Once‑Daily Use: The recommended dose is 5 mg taken orally once daily at approximately the same time each day, with or without food. For patients who are starting therapy or who experience side effects, the dose may be reduced to 2.5 mg once daily. Sexual stimulation is required for an erection to occur.
• Benign Prostatic Hyperplasia (BPH) or ED plus BPH: The recommended dose is 5 mg taken once daily. If the 5 mg dose is not tolerated, the dose may be reduced to 2.5 mg once daily.
• Renal impairment: Once‑daily use is not recommended in patients with severe renal impairment (CrCl ≤ 30 mL/min). In patients with mild to moderate renal impairment (CrCl 31‑80 mL/min), no dose adjustment is required, but a starting dose of 2.5 mg may be considered.
• Hepatic impairment: In patients with mild or moderate hepatic impairment (Child‑Pugh A or B), the recommended dose is 2.5 mg once daily. Once‑daily use is not recommended in severe hepatic impairment (Child‑Pugh C).
• Concomitant use with CYP3A4 inhibitors: When tadalafil is co‑administered with potent CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole), once‑daily use is not recommended. For moderate CYP3A4 inhibitors (e.g., erythromycin, clarithromycin, fluconazole), no dose adjustment is specifically recommended, but caution is advised; the 2.5 mg dose may be considered.
• Administration: Swallow the tablet whole with a glass of water. Tadalafil may be taken with or without food. Take at approximately the same time each day to establish a routine. Do not take more than one tablet per day.
• Missed dose: If a dose is missed, take it as soon as remembered on the same day. If it is close to the time of the next scheduled dose, skip the missed dose and take the next dose at the usual time. Do not take a double dose to make up for a missed one.

Side Effects and Contraindications

• Very common side effects (≥ 10%): Headache (3‑5% in daily dosing studies) and dyspepsia (3‑4%).
• Common side effects (1‑10%): Back pain (2‑3%), myalgia (muscle pain, 2‑3%), nasal congestion (1‑2%), flushing (1‑2%), pain in the limbs, and dizziness. Back pain and myalgia typically occur 12 to 24 hours after dosing and resolve within 48 hours. These effects tend to be less frequent with once‑daily dosing compared with on‑demand higher doses.
• Uncommon but serious side effects: Priapism (prolonged, painful erection lasting more than 4 hours), sudden vision loss in one or both eyes (NAION), sudden decrease or loss of hearing, and serious cardiovascular events (myocardial infarction, stroke, ventricular arrhythmia) occurring in temporal association with sexual activity and tadalafil use. Hypotension and syncope have also been reported, particularly in patients taking concomitant antihypertensives or alpha‑blockers.
• Post‑marketing experience: Hypersensitivity reactions including Stevens‑Johnson syndrome, exfoliative dermatitis, and angioedema have been reported rarely. Cases of priapism and prolonged erections have been observed.
• Contraindications: Concomitant use of organic nitrates in any form (e.g., nitroglycerin, isosorbide mononitrate) or nitric oxide donors (e.g., amyl nitrite). Concomitant use of riociguat (a guanylate cyclase stimulator). Known hypersensitivity to tadalafil or any component of the product. Severe cardiovascular disease or conditions in which sexual activity is inadvisable. Recent myocardial infarction (within 6 months) or stroke. The contraindications apply regardless of the dose strength or dosing regimen.

Drug Interactions

• Nitrates and nitric oxide donors — contraindicated: Co‑administration with any organic nitrate or nitrite is absolutely contraindicated because it can cause profound hypotension that may result in fainting, shock, or death. If a patient taking tadalafil requires emergency nitrate administration for angina, at least 48 hours should elapse after the last dose of tadalafil, and nitrates should be administered only under close medical supervision.
• Guanylate cyclase stimulators — contraindicated: Riociguat (Adempas®) should not be co‑administered with tadalafil due to the risk of additive hypotensive effects.
• Alpha‑blockers: Concomitant use may lead to additive vasodilation and symptomatic hypotension. Tadalafil should be started at the lowest recommended daily dose (2.5 mg) when added to alpha‑blocker therapy, and the patient should be stable on the alpha‑blocker before initiating tadalafil.
• Potent CYP3A4 inhibitors: Ketoconazole, itraconazole, ritonavir, and other potent CYP3A4 inhibitors significantly increase tadalafil plasma levels. Once‑daily use of tadalafil is not recommended with these inhibitors.
• Moderate CYP3A4 inhibitors: Erythromycin, clarithromycin, and fluconazole may increase tadalafil exposure. No specific dose adjustment is required, but caution is advised; the 2.5 mg dose may be considered.
• Antihypertensives: Tadalafil may produce additive blood‑pressure‑lowering effects. Most patients tolerate this combination without significant adverse effects; however, those with pre‑existing hypotension should be cautious.
• Alcohol: Alcohol may increase the risk of headache, dizziness, and hypotension. Patients should limit alcohol intake, particularly heavy drinking.
• Grapefruit juice: Grapefruit juice is a weak CYP3A4 inhibitor; no dose adjustment is required, but it should be consumed in moderation.

Practical Advice

• Administration: Take Cialis Daily exactly as prescribed. Swallow one tablet whole with a glass of water at approximately the same time each day. It may be taken with or without food. A daily routine helps ensure you get consistent coverage. Sexual stimulation is required for an erection; the medication does not cause an erection on its own. Do not take more than one tablet per day.
• Monitoring: No routine laboratory monitoring is required. Men with underlying cardiovascular risk factors should have a medical evaluation before starting treatment for ED or BPH. If you experience chest pain during sexual activity, stop immediately and seek medical attention. Monitor for any visual or hearing changes, and report them to your doctor promptly. For patients taking tadalafil for BPH, urinary symptoms should be re‑evaluated periodically. If you are switching from on‑demand tadalafil to daily dosing, ensure you do not take both forms concurrently.
• Storage: Store at room temperature (15‑30 °C) in a dry place, protected from moisture and heat. Keep out of the reach and sight of children.
• Lifestyle: Cialis Daily is a treatment, not a cure. Addressing underlying causes—such as quitting smoking, reducing alcohol consumption, losing weight, and controlling diabetes and hypertension—can improve erectile function and urinary symptoms. Never share your medication, and do not take Cialis Daily with other PDE5 inhibitors (e.g., sildenafil, vardenafil) or other tadalafil‑containing products.
• Emergency information: If you develop an erection that lasts longer than 4 hours (priapism) or experience sudden vision or hearing loss, stop taking Cialis Daily and go to the nearest emergency department immediately. If you need to be seen by a doctor for any reason, always tell them you are taking tadalafil. If you experience chest pain, do not take nitrates without first informing the treating physician that you have taken tadalafil, and ensure at least 48 hours have passed since your last dose.
• Disposal: Return unused or expired tablets to a pharmacy for safe disposal. Do not flush down the toilet or discard in household waste.

Alternative Medications

• Tadalafil on‑demand (Cialis® 10 mg, 20 mg): For men who do not require daily coverage, tadalafil can be used as needed at higher doses, with a similar 36‑hour window of effectiveness.
• Sildenafil (Viagra®): A short‑acting PDE5 inhibitor taken as needed, with a duration of 4‑6 hours. It is available as a generic and can be a suitable alternative for men who prefer a shorter‑acting agent.
• Vardenafil (Levitra®): A PDE5 inhibitor similar to sildenafil, with a duration of 4‑5 hours. Available as a tablet and an orally disintegrating tablet.
• Avanafil (Stendra®): A fast‑acting PDE5 inhibitor with an onset of as little as 15 minutes and a duration similar to sildenafil.
• For BPH only: Alpha‑blockers such as tamsulosin (Flomax®) and silodosin (Rapaflo®) are first‑line oral agents. 5‑alpha‑reductase inhibitors such as finasteride (Proscar®) and dutasteride (Avodart®) are used for larger prostates.
• Non‑pharmacological options: Vacuum erection devices, penile implants, psychological counselling for psychogenic ED, and minimally invasive surgical therapies for BPH are available for patients who do not respond to or tolerate medical therapy.

Clinical Efficacy

The efficacy of tadalafil once daily for the treatment of ED has been demonstrated in several randomized, double‑blind, placebo‑controlled clinical trials. In a pivotal study, tadalafil 5 mg once daily significantly improved erectile function scores compared with placebo, with improvements seen across all severity levels of ED. In men with mild to moderate ED, the 2.5 mg dose was also effective, with a lower incidence of side effects. The once‑daily regimen was associated with high satisfaction rates and improved spontaneity, as couples did not need to time intercourse around a pill. For BPH, tadalafil 5 mg once daily significantly improved the International Prostate Symptom Score (IPSS) compared with placebo, with a mean reduction of 4.8‑5.6 points from baseline, and improved peak urinary flow rate. The combination of ED and BPH benefits in a single daily tablet is a unique feature of tadalafil. The once‑daily dosing is particularly useful for men who anticipate frequent sexual activity (at least twice weekly) and for those who require continuous treatment for urinary symptoms. The safety profile of the lower daily doses is favourable, with a lower incidence of typical PDE5 inhibitor side effects such as headache and dyspepsia compared with the higher on‑demand doses.

Important:

Cialis Daily (tadalafil) is a prescription medication that should be used only under the supervision of a qualified healthcare professional. The most critical safety warning is that tadalafil, in any form, must never be taken with any form of organic nitrate (e.g., nitroglycerin, isosorbide mononitrate, “poppers”). This combination can cause a severe, sudden, and potentially fatal drop in blood pressure. If you experience chest pain or an erection lasting longer than 4 hours (priapism), stop using the medication and seek emergency medical attention immediately. This product is for adult men and is not intended for use by women or children. Do not take Cialis Daily with other PDE5 inhibitors or other tadalafil‑containing products. If you are taking alpha‑blockers, you should be stable on that therapy before starting daily tadalafil, and the tadalafil dose may need to be reduced. Do not drink large amounts of alcohol. If you experience sudden vision loss, sudden hearing loss, or a prolonged erection, seek immediate medical attention. This information is not a substitute for professional medical advice, diagnosis, or treatment.

Get Generic Cialis Daily - Shipping across Canada